Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma

This publication has 35 references indexed in Scilit:

• IDH1 and IDH2 have critical roles in 2-hydroxyglutarate production in D-2-hydroxyglutarate dehydrogenase depleted cells
  Biochemical and Biophysical Research Communications, 2012
• 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
  Nature Medicine, 2012
• Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
  The Oncologist, 2011
• IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
  The Journal of Pathology, 2011
• Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
  New England Journal of Medicine, 2009
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme
  Science, 2008
• In vivo localized ¹H MR spectroscopy of rat testes: Stimulated echo acquisition mode (STEAM) combined with short TI inversion recovery (STIR) improves the detection of metabolite signals
  Magnetic Resonance in Medicine, 2006
• ¹H and ¹³C NMR study of 2‐hydroxyglutaric acid and its lactone
  Magnetic Resonance in Chemistry, 2002
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra
  Magnetic Resonance in Medicine, 1993
• Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils
  Magnetic Resonance in Medicine, 1993